178 related articles for article (PubMed ID: 22075622)
1. Human choriocarcinomas: placental growth factor-dependent preclinical tumor models.
Bagley RG; Ren Y; Kurtzberg L; Weber W; Bangari D; Brondyk W; Teicher BA
Int J Oncol; 2012 Feb; 40(2):479-86. PubMed ID: 22075622
[TBL] [Abstract][Full Text] [Related]
2. Placental growth factor upregulation is a host response to antiangiogenic therapy.
Bagley RG; Ren Y; Weber W; Yao M; Kurtzberg L; Pinckney J; Bangari D; Nguyen C; Brondyk W; Kaplan J; Teicher BA
Clin Cancer Res; 2011 Mar; 17(5):976-88. PubMed ID: 21343374
[TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial growth factors and their receptors and regulators in gestational trophoblastic diseases and normal placenta.
Singh M; Kindelberger D; Nagymanyoki Z; Ng SW; Quick CM; Yamamoto H; Fichorova R; Fulop V; Berkowitz RS
J Reprod Med; 2012; 57(5-6):197-203. PubMed ID: 22696812
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin-(1-7) reduces proliferation and angiogenesis of human prostate cancer xenografts with a decrease in angiogenic factors and an increase in sFlt-1.
Krishnan B; Torti FM; Gallagher PE; Tallant EA
Prostate; 2013 Jan; 73(1):60-70. PubMed ID: 22644934
[TBL] [Abstract][Full Text] [Related]
5. sFLT01: a novel fusion protein with antiangiogenic activity.
Bagley RG; Kurtzberg L; Weber W; Nguyen TH; Roth S; Krumbholz R; Yao M; Richards B; Zhang M; Pechan P; Schmid S; Scaria A; Kaplan J; Teicher BA
Mol Cancer Ther; 2011 Mar; 10(3):404-15. PubMed ID: 21252283
[TBL] [Abstract][Full Text] [Related]
6. Tumor necrosis factor-α regulates angiogenesis of BeWo cells via synergy of PlGF/VEGFR1 and VEGF-A/VEGFR2 axes.
Tanaka K; Watanabe M; Tanigaki S; Iwashita M; Kobayashi Y
Placenta; 2018 Dec; 74():20-27. PubMed ID: 30591201
[TBL] [Abstract][Full Text] [Related]
7. Altered tumor vessel maturation and proliferation in placenta growth factor-producing tumors: potential relationship to post-therapy tumor angiogenesis and recurrence.
Taylor AP; Rodriguez M; Adams K; Goldenberg DM; Blumenthal RD
Int J Cancer; 2003 Jun; 105(2):158-64. PubMed ID: 12673673
[TBL] [Abstract][Full Text] [Related]
8. Trophoblastic vasculogenic mimicry in gestational choriocarcinoma.
Shih IeM
Mod Pathol; 2011 May; 24(5):646-52. PubMed ID: 21217646
[TBL] [Abstract][Full Text] [Related]
9. PlGF and VEGF-A Regulate Growth of High-Risk MYCN-Single Copy Neuroblastoma Xenografts via Different Mechanisms.
Zins K; Kovatchki D; Lucas T; Abraham D
Int J Mol Sci; 2016 Sep; 17(10):. PubMed ID: 27669225
[TBL] [Abstract][Full Text] [Related]
10. Placental growth factor-1 attenuates vascular endothelial growth factor-A-dependent tumor angiogenesis during beta cell carcinogenesis.
Schomber T; Kopfstein L; Djonov V; Albrecht I; Baeriswyl V; Strittmatter K; Christofori G
Cancer Res; 2007 Nov; 67(22):10840-8. PubMed ID: 18006829
[TBL] [Abstract][Full Text] [Related]
11. VEGF-Grab Enhances the Efficacy of Radiation Therapy by Blocking VEGF-A and Treatment-Induced PlGF.
Park I; Yang H; Park JS; Koh GY; Choi EK
Int J Radiat Oncol Biol Phys; 2018 Nov; 102(3):609-618. PubMed ID: 30017791
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of placental growth factor in renal cell carcinoma.
Bessho H; Wong B; Huang D; Siew EY; Huang D; Tan J; Ong CK; Tan SY; Matsumoto K; Iwamura M; Teh BT
Anticancer Res; 2015 Jan; 35(1):531-41. PubMed ID: 25550599
[TBL] [Abstract][Full Text] [Related]
13. Prognostic impact of placenta growth factor and vascular endothelial growth factor A in patients with breast cancer.
Maae E; Olsen DA; Steffensen KD; Jakobsen EH; Brandslund I; Sørensen FB; Jakobsen A
Breast Cancer Res Treat; 2012 May; 133(1):257-65. PubMed ID: 22270936
[TBL] [Abstract][Full Text] [Related]
14. Tumor cell-derived placental growth factor sensitizes antiangiogenic and antitumor effects of anti-VEGF drugs.
Hedlund EM; Yang X; Zhang Y; Yang Y; Shibuya M; Zhong W; Sun B; Liu Y; Hosaka K; Cao Y
Proc Natl Acad Sci U S A; 2013 Jan; 110(2):654-9. PubMed ID: 23267058
[TBL] [Abstract][Full Text] [Related]
15. Placental growth factor neutralising antibodies give limited anti-angiogenic effects in an in vitro organotypic angiogenesis model.
Brave SR; Eberlein C; Shibuya M; Wedge SR; Barry ST
Angiogenesis; 2010 Dec; 13(4):337-47. PubMed ID: 20953695
[TBL] [Abstract][Full Text] [Related]
16. PlGF blockade does not inhibit angiogenesis during primary tumor growth.
Bais C; Wu X; Yao J; Yang S; Crawford Y; McCutcheon K; Tan C; Kolumam G; Vernes JM; Eastham-Anderson J; Haughney P; Kowanetz M; Hagenbeek T; Kasman I; Reslan HB; Ross J; Van Bruggen N; Carano RA; Meng YJ; Hongo JA; Stephan JP; Shibuya M; Ferrara N
Cell; 2010 Apr; 141(1):166-77. PubMed ID: 20371352
[TBL] [Abstract][Full Text] [Related]
17. Effects of anti-β2-glycoprotein I antibody on PlGF, VEGF and sVEGFR1 production from cultured choriocarcinoma cell line.
Ichikawa G; Yamamoto T; Chishima F; Nakamura A; Kuno S; Murase T; Suzuki M
J Obstet Gynaecol Res; 2011 Aug; 37(8):1076-83. PubMed ID: 21501325
[TBL] [Abstract][Full Text] [Related]
18. α-Solanine Inhibits Proliferation, Invasion, and Migration, and Induces Apoptosis in Human Choriocarcinoma JEG-3 Cells In Vitro and In Vivo.
Gu T; Yuan W; Li C; Chen Z; Wen Y; Zheng Q; Yang Q; Xiong X; Yuan A
Toxins (Basel); 2021 Mar; 13(3):. PubMed ID: 33805658
[TBL] [Abstract][Full Text] [Related]
19. FP3: a novel VEGF blocker with anti-angiogenic and anti-tumor effects.
Gao W; Jin K; Lan H; Han N; Cao F; Teng L
Hepatogastroenterology; 2012; 59(120):2543-7. PubMed ID: 22534543
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of malignant trophoblastic cell proliferation in vitro and in vivo by melatonin.
Shiu SY; Xi SC; Xu JN; Mei L; Pang SF; Yao KM; Wong JT
Life Sci; 2000 Sep; 67(17):2059-74. PubMed ID: 11057756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
